PDL is pleased to provide further information to pharmacists practising in Queensland about the UTIPP-Q pilot program and recent announcements. The following advice is directed
PDL Professional Officers have observed an increase in formal requests for information regarding dispensed medicines from the Real Time Prescription Monitoring (RTPM) sections of health
All students and interns are registered with AHPRA, and therefore have the responsibility to comply with the guidelines and protocols associated with registration. As pharmacists
PDL has previously informed members likely to be working in Queensland of the mandatory requirements of the QScript real-time prescription monitoring system. The practice alerts
PDL is aware of multiple instances where a pharmacist has not realised a prescription needs to be compounded. This may be due to misinterpretation of
PDL would like to remind pharmacists that ALL private prescriptions presented for potent opioids should be treated with high suspicion. Prescriptions for high-dose fentanyl patches and oxycodone tablets make up more
As pharmacists working in Queensland should be aware, integration of the QScript system into practice became mandated on Thursday, 28 October 2021. Legal and professional responsibility It
Most pharmacists would be aware that the Pharmacy Regulation Authority SA (PRASA) has been undertaking an inspection program of pharmacy premises for the last nine
Queensland Health has released information about the Queensland real time prescription monitoring system, QScript, in anticipation of its introduction later this year. As the recognised
There are certain medications that appear in notifications to PDL frequently. While some of these medications are considered low risk and have less potential for
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.